Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
OVID
OVID
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
OVID News
Ovid Therapeutics Stock Surges 18% on Positive OV329 Data
Mar 18 2026
Fool
Ovid Therapeutics' OV329 Shows Promising Safety and Efficacy in Phase 1 Study
Mar 18 2026
NASDAQ.COM
Coherent Corp. Shares Rise 6% Ahead of OFC 2026 Showcase
Mar 18 2026
NASDAQ.COM
Health Care Stocks Decline in Premarket Trading
Mar 18 2026
Yahoo Finance
Ovid Therapeutics Shares Surge 26% on Positive Clinical Data and Financing
Mar 18 2026
NASDAQ.COM
Ovid Therapeutics Shares Surge Over 40% on Positive OV329 Drug Results
Mar 18 2026
seekingalpha
Ovid Therapeutics Advances KCC2 Oral Activator OV4071 Clinical Trial Plans
Dec 18 2025
Newsfilter
Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer to Advance CNS Drug Development
Dec 02 2025
Globenewswire
Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer to Advance CNS Drug Development
Dec 02 2025
Newsfilter
Ovid Therapeutics Appoints Petra Kaufmann as Chief Medical Officer
Dec 02 2025
NASDAQ.COM
HC Wainwright & Co. Reaffirms Buy Rating for Ovid Therapeutics and Increases Price Target to $2
Nov 24 2025
Benzinga
Alto Neuroscience Analyst Starts Coverage Optimistically; Check Out the Top 5 Initiations for Monday
Nov 17 2025
Benzinga
Ovid Therapeutics (OVID) Posts Q3 Loss, Falls Short of Revenue Projections
Nov 12 2025
NASDAQ.COM
AnaptysBio, Inc. (ANAB) Exceeds Expectations for Q3 Earnings and Revenue
Nov 05 2025
NASDAQ.COM
Ovid Therapeutics (OVID) Sees 42.98% Increase Over the Past Week: Key Insights to Consider
Oct 06 2025
NASDAQ.COM
Ovid Soars Following Encouraging Findings from Epilepsy Research
Oct 03 2025
SeekingAlpha
Show More News
